Joint Breakfast Meeting of the ACR JDM Working Group and IMACS

Monday October 27, 2008; Time 6:15 - 08:30 AM

Location: Club Room, San Francisco Marriott, San Francisco, CA

Breakfast Service begins
0630 - 0715
Myositis Research Updates
Moderators: Drs. Bianca Lang and Lisa Rider
1. PRINTO JDM Trial Dr. Nicola Ruperto
2. CARRA - JDM Practice Survey Dr. Adam Huber
3. NIAMS JDM Registry and other JDM research Dr. Lauren Pachman
4. UK JDM Research Group and PrES JDM Network Dr. Clarissa Pilkington
5. UKCRN/MCRN- Research Network with JDM interest group Dr. Lucy Wedderburn
6. PROMETHEUS Methotrexate Trial for PM/DM Dr. Jiri Vencovsky
7. Presenting Features of Myositis Dr. Snejana Vetrila
8. MITAX Computer Program (BLIPS) Dr. David Isenberg
9. IMACS Trials Repository Dr. Lisa Rider
10. Myositis Classification Criteria Project Dr. Ingrid Lundberg
11. MYOGEN Project Dr. Frederick Miller
0715 - 0830
Minisymposium - Biologic Therapies in Myositis: Current Status, Future Directions
Moderators: Drs. Frederick Miller and David Isenberg
1.  Anti-Tumor Necrosis Factor Agents:
  • Infliximab
  • Etanercept
Dr. Mark Gourley
Dr. Lauren Pachman
2. Anakinra Dr. Ingrid Lundberg
3. Rituximab and other B cell Therapies Dr. Chester Oddis
4. Anti-Interferon Alpha Dr. Barbara White
5. Other Biologics on the Horizon Dr. Vibeke Strand
6. Open Discussion: Other Experiences, Thoughts on New Trials

The generous support of Amgen, The Myositis Association, and The Cure JM Foundation as sponsors of this meeting is gratefully acknowledged.